A survey of marine natural compounds and their derivatives with anti-Cancer activity reported in 2010

Molecules

Volumn 16, Issue 7, 2011, Pages 5629-5646

  Schumacher, Marc ^a   Kelkel, Mareike ^a   Dicato, Mario ^a   Diederich, Marc ^a  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

Author keywords

Cancer; Marine anticancer compounds; Natural analogues; Synthetic derivatives

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; PLANT MEDICINAL PRODUCT;

ANIMAL; AQUATIC SPECIES; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; HUMAN; NEOPLASM; REVIEW; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; AQUATIC ORGANISMS; BIOLOGICAL AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; PLANT PREPARATIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79960812511     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16075629     Document Type: Review

References (102)

1. WHO. Fact Sheet No297. Available online: http://www.who.int/mediacentre/ factsheets/fs297/en/ (accessed on 20 March 2011).
2. D'Incalci, M.; Galmarini, C.M. A review of trabectedin (ET-743): A unique mechanism of action. Mol. Cancer Ther. 2010, 9, 2157-2163.
3. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477. (Pubitemid 46595760)
4. Dumontet, C.; Jordan, M.A. Microtubule-binding agents: A dynamic field of cancer therapeutics. Nat. Rev. Drug Discov. 2010, 9, 790-803.
5. Gullett, N.P.; Ruhul Amin, A.R.; Bayraktar, S.; Pezzuto, J.M.; Shin, D.M.; Khuri, F.R.; Aggarwal, B.B.; Surh, Y.J.; Kucuk, O. Cancer prevention with natural compounds. Semin. Oncol. 2010, 37, 258-281.
6. Villa, F.A.; Gerwick, L. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Immunopharmacol. Immunotoxicol. 2010, 32, 228-237.
7. Juncker, T.; Cerella, C.; Teiten, M.H.; Morceau, F.; Schumacher, M.; Ghelfi, J.; Gaascht, F.; Schnekenburger, M.; Henry, E.; Dicato, M.; et al. UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells. Biochem. Pharmacol. 2011, 81, 13-23.
8. Folmer, F.; Jaspars, M.; Dicato, M.; Diederich, M. Photosynthetic marine organisms as a source of anticancer compounds. Phytochem. Rev. 2010, 9, 557-479.
9. Scheuer, P.J. Some marine ecological phenomena: Chemical basis and biomedical potential. Science 1990, 248, 173-177.
10. Miloslavich, P.; Diaz, J.M.; Klein, E.; Alvarado, J.J.; Diaz, C.; Gobin, J.; Escobar-Briones, E.; Cruz-Motta, J.J.; Weil, E.; Cortes, J.; et al. Marine biodiversity in the Caribbean: Regional estimates and distribution patterns. PLoS One 2010, 5, e11916.
11. Fautin, D.; Dalton, P.; Incze, L.S.; Leong, J.A.; Pautzke, C.; Rosenberg, A.; Sandifer, P.; Sedberry, G.; Tunnell, J.W., Jr.; Abbott, I.; et al. An overview of marine biodiversity in United States waters. PLoS One 2010, 5, e11914.
12. Butler, A.J.; Rees, T.; Beesley, P.; Bax, N.J. Marine biodiversity in the Australian region. PLoS One 2010, 5, e11831.
13. Census of marine life. Available online: http://www.coml.org/about- census/ (accessed on 20 March 2011).
14. Anand, P.; Thomas, S.G.; Kunnumakkara, A.B.; Sundaram, C.; Harikumar, K.B.; Sung, B.; Tharakan, S.T.; Misra, K.; Priyadarsini, I.K.; Rajasekharan, K.N.; et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem. Pharmacol. 2008, 76, 1590-1611.
15. Yadav, B.; Taurin, S.; Rosengren, R.J.; Schumacher, M.; Diederich, M.; Somers-Edgar, T.J.; Larsen, L. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorg. Med. Chem. 2010, 18, 6701-6707.
16. Floss, H.G. Combinatorial biosynthesis-Potential and problems. J. Biotechnol. 2006, 124, 242-257. (Pubitemid 43816127)
17. Wender, P.A.; Baryza, J.L.; Brenner, S.E.; Dechristopher, B.A.; Loy, B.A.; Schrier, A.J.; Verma, V.A. Organic synthesis toward small-molecule probes and drugs special feature: Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity. Proc. Natl. Acad. Sci. USA 2011, 108, 6721-6726.
18. Wender, P.A.; Miller, B.L. Synthesis at the molecular frontier. Nature 2009, 460, 197-201.
19. Penesyan, A.; Kjelleberg, S.; Egan, S. Development of novel drugs from marine surface associated microorganisms. Mar. Drugs 2010, 8, 438-459.
20. Ebada, S.S.; Lin, W.; Proksch, P. Bioactive sesterterpenes and triterpenes from marine sponges: Occurrence and pharmacological significance. Mar. Drugs 2010, 8, 313-346.
21. Lin, X.; Liu, M.; Hu, C.; Liao, D.J. Targeting cellular proapoptotic molecules for developing anticancer agents from marine sources. Curr. Drug Targets 2010, 11, 708-715.
22. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2010, 27, 165-237.
23. Schumacher, M.; Kelkel, M.; Dicato, M.; Diederich, M. Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer. Biotechnol. Adv. 2011, doi:10.1016/j.biotechadv.2011.02.002.
24. Folmer, F.; Jaspars, M.; Schumacher, M.; Dicato, M.; Diederich, M. Marine natural products targeting phospholipases A2. Biochem. Pharmacol. 2010, 80, 1793-1800.
25. Folmer, F.; Jaspars, M.; Dicato, M.; Diederich, M. Marine natural products as targeted modulators of the transcription factor NF-kappaB. Biochem. Pharmacol. 2008, 75, 603-617.
26. Oh, H.; Jensen, P.R.; Murphy, B.T.; Fiorilla, C.; Sullivan, J.F.; Ramsey, T.; Fenical, W. Cryptosphaerolide, a cytotoxic Mcl-1 inhibitor from a marine-derived ascomycete related to the genus Cryptosphaeria. J. Nat. Prod. 2010, 73, 998-1001.
27. Michels, J.; Johnson, P.W.; Packham, G. Mcl-1. Int. J. Biochem. Cell Biol. 2005, 37, 267-271.
28. Guzman, E.A.; Johnson, J.D.; Linley, P.A.; Gunasekera, S.E.; Wright, A.E. A novel activity from an old compound: Manzamine A reduces the metastatic potential of AsPC-1 pancreatic cancer cells and sensitizes them to TRAIL-induced apoptosis. Invest. New Drugs 2010, Epub ahead of print.
29. Hamann, M.; Alonso, D.; Martin-Aparicio, E.; Fuertes, A.; Perez-Puerto, M.J.; Castro, A.; Morales, S.; Navarro, M.L.; Del Monte-Millan, M.; Medina, M.; et al. Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease. J. Nat. Prod. 2007, 70, 1397-1405. (Pubitemid 47584577)
30. Garrido, L.; Zubia, E.; Ortega, M.J.; Salva, J. Isolation and structure elucidation of new cytotoxic steroids from the gorgonian Leptogorgia sarmentosa. Steroids 2000, 65, 85-88. (Pubitemid 30009770)
31. Boonananwong, S.; Kongkathip, B.; Kongkathip, N. First synthesis of 3,16,20-polyoxygenated cholestanes, new cytotoxic steroids from the gorgonian Leptogorgia sarmentosa. Steroids 2008, 73, 1123-1127.
32. Bunyathaworn, P.; Boonananwong, S.; Kongkathip, B.; Kongkathip, N. Further study on synthesis and evaluation of 3,16,20-polyoxygenated steroids of marine origin and their analogs as potent cytotoxic agents. Steroids 2010, 75, 432-444.
33. Ainnslie, R.D.; Barchi, J.J.; Kuniyoshi, M.; Moore, R.E.; Myndersee, J.S. Structure of Malyngamide C. J. Org. Chem. 1985, 50, 2859-2862.
34. Kwan, J.C.; Teplitski, M.; Gunasekera, S.P.; Paul, V.J.; Luesch, H. Isolation and biological evaluation of 8-epi-malyngamide C from the Floridian marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 2010, 73, 463-466.
35. Ahmadi, A.; Mohagheghi, M.; Karimi, M.; Golestanha, S.A.; Naseri, M.; Faghihzadeh, S.; Habibi, G. Therapeutic effects of HESA-A in patients with end-stage metastatic cancers. Integr. Cancer Ther. 2010, 9, 32-35.
36. Ahmadi, A.; Naderi, G.; Asgary, S. Evaluation of hepatoprotective potential of HESA-A (a marine compound) pretreatment against thioacetamide-induced hepatic damage in rabbits. Drugs Exp. Clin. Res. 2005, 31, 1-6. (Pubitemid 40461565)
37. Amrollah, A.; Gholamreza, H.; Mehdi, F. Anticancer effects of HESA-A: An herbal marine compound. Chin. J. Integr. Med. 2010, 16, 366-367.
38. Moallem, S.; Ahmadi, A.; Moshafi, M.; Taghavi, M. Teratogenic effects of HESA-A, a natural anticancer product from Iran, in mice. Hum. Exp. Toxicol. 2010, doi:10.1177/0960327110379521.
39. Ahmadi, A.; Mohagheghi, M.; Karimi, M.; Seyed Ali, G.; Naseri, M. Anticancer effects of HESA-A in patients with metastatic colon cancer. Integr. Cancer Ther. 2009, 8, 71-74.
40. Ahmadi, A.; Ghanbari, H.; Soheilian, M.; Naseri, M. The EFFEct of HESA-A (natural drug) on visual acuity in age related macular degeneration: A randomized double blind controlled clinical trial. Afr. J. Tradit. Complement. Altern. Med. 2009, 6, 549-553.
41. Pettit, G.R.; Cichacz, Z.A.; Gao, F.; Herald, C.L.; Boyd, M.R.; Schmidt, J.M.; Hooper, J.N. Isolation and structure of spongistatin 1. J. Org. Chem. 1993, 58, 1302-1304. (Pubitemid 23138825)
42. Bai, R.; Cichacz, Z.A.; Herald, C.L.; Pettit, G.R.; Hamel, E. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Mol. Pharmacol. 1993, 44, 757-766. (Pubitemid 23317288)
43. Catassi, A.; Cesario, A.; Arzani, D.; Menichini, P.; Alama, A.; Bruzzo, C.; Imperatori, A.; Rotolo, N.; Granone, P.; Russo, P. Characterization of apoptosis induced by marine natural products in non small cell lung cancer A549 cells. Cell. Mol. Life Sci. 2006, 63, 2377-2386. (Pubitemid 44653047)
44. Schyschka, L.; Rudy, A.; Jeremias, I.; Barth, N.; Pettit, G.R.; Vollmar, A.M. Spongistatin 1: A new chemosensitizing marine compound that degrades XIAP. Leukemia 2008, 22, 1737-1745.
45. Schneiders, U.M.; Schyschka, L.; Rudy, A.; Vollmar, A.M. BH3-only proteins Mcl-1 and Bim as well as endonuclease G are targeted in spongistatin 1-induced apoptosis in breast cancer cells. Mol. Cancer Ther. 2009, 8, 2914-2925.
46. Hayward, M.M.; Roth, R.M.; Duffy, K.J.; Dalko, P.I.; Stevens, K.L.; Guo, J.; Kishi, Y. Total synthesis of altohyrtin A (Spongistatin 1): Part 2. Angew. Chem. Int. Ed. 1998, 37, 192-196.
47. Paterson, I.; Chen, D.Y.K.; Coster, M.J.; Aceña, J.L.; Bach, J.; Wallace, D.J. The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: Fragment couplings, completion of the synthesis, analogue generation and biological evaluation. Org. Biomol. Chem. 2005, 3, 2431-2440. (Pubitemid 41028053)
48. Wagner, C.E.; Wang, Q.; Melamed, A.; Fairchild, C.R.; Wild, R.; Heathcock, C.H. Synthesis and biological evaluation of analogs of altohyrtin C (spongistatin 2). Tetrahedron 2008, 64, 124-136. (Pubitemid 350161799)
49. Smith, A.B., 3rd; Risatti, C.A.; Atasoylu, O.; Bennett, C.S.; Tendyke, K.; Xu, Q. Design, synthesis, and biological evaluation of EF- and ABEF- analogues of (+)-spongistatin 1. Org. Lett. 2010, 12, 1792-1795.
50. Kobayashi, J.; Tsuda, M.; Murayama, T.; Nakamura, H.; Ohizumi, Y.; Ishibashi, M.; Iwamura, M.; Ohta, T.; Nozoe, S. Ageliferins, potent actomyosin Atpase activators from the Okinawan marine sponge Agelas sp. Tetrahedron 1990, 46, 5579-5586. (Pubitemid 20282416)
51. Pettit, G.R.; Herald, C.L.; Leet, J.E.; Gupta, R.; Schaufelberger, D.E.; Bates, R.B.; Clewlow, P.J.; Doubek, D.L.; Manfredi, K.P.; Rützler, K.; et al. Antineoplastic agents. 168. Isolation and structure of axinohydantoin. Can. J. Chem. 1990, 68, 1621-1624. (Pubitemid 20352788)
52. Ishida, K.; Ishibashi, M.; Shigemori, H.; Sasaki, T.; Kobayashi, J. Agelasine G, a new antileukemic alkaloid from the Okinawan marine sponge Agelas sp. Chem. Pharm. Bull. (Tokyo) 1992, 40, 766-767.
53. Pettit, G.R.; McNulty, J.; Herald, D.L.; Doubek, D.L.; Chapuis, J.C.; Schmidt, J.M.; Tackett, L.P.; Boyd, M.R. Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana. J. Nat. Prod. 1997, 60, 180-183. (Pubitemid 27098570)
54. Xiong, S.; Pang, H.D.; Fan, J.; Ge, F.; Yang, X.X.; Liu, Q.Y.; Liao, X.J.; Xu, S.H. In vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of action. Br. J. Pharmacol. 2010, 159, 909-918.
55. Cipres, A.; O'Malley, D.P.; Li, K.; Finlay, D.; Baran, P.S.; Vuori, K. Sceptrin, a marine natural compound, inhibits cell motility in a variety of cancer cell lines. ACS Chem. Biol. 2010, 5, 195-202.
56. Keifer, P.A.; Schwartz, R.E.; Koker, M.E.S.; Hughes, R.G.J.; Rittschof, D.; Rinehart, K.L. Bioactive bromopyrrole metabolites from the Caribbean sponge Agelas conifera. J. Org. Chem. 1991, 56, 2965-2975.
57. Inman, W.D.; Bray, W.M.; Gassner, N.C.; Lokey, R.S.; Tenney, K.; Shen, Y.Y.; Tendyke, K.; Suh, T.; Crews, P. A beta-carboline alkaloid from the Papua New Guinea marine sponge hyrtios reticulatus. J. Nat. Prod. 2010, 73, 255-257.
58. Daugan, A.; Grondin, P.; Ruault, C.; Le Monnier de Gouville, A.C.; Coste, H.; Linget, J.M.; Kirilovsky, J.; Hyafil, F.; Labaudiniere, R. The discovery of tadalafil: A novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a- hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4- dione analogues. J. Med. Chem. 2003, 46, 4533-4542. (Pubitemid 37238754)
59. Trujillo, J.I.; Meyers, M.J.; Anderson, D.R.; Hegde, S.; Mahoney, M.W.; Vernier, W.F.; Buchler, I.P.; Wu, K.K.; Yang, S.; Hartmann, S.J.; et al. Novel tetrahydro-beta-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorg. Med. Chem. Lett. 2007, 17, 4657-4663. (Pubitemid 47061507)
60. Till, M.; Prinsep, M.R. 5-Bromo-8-methoxy-1-methyl-beta-carboline, an alkaloid from the New Zealand marine bryozoan Pterocella vesiculosa. J. Nat. Prod. 2009, 72, 796-798.
61. Zheng, L.; Yan, X.; Han, X.; Chen, H.; Lin, W.; Lee, F.S.; Wang, X. Identification of norharman as the cytotoxic compound produced by the sponge (Hymeniacidon perleve)-associated marine bacterium Pseudoalteromonas piscicida and its apoptotic effect on cancer cells. Biotechnol. Appl. Biochem. 2006, 44, 135-142. (Pubitemid 43844651)
62. Rashid, M.A.; Gustafson, K.R.; Boyd, M.R. New cytotoxic N-methylated beta-carboline alkaloids from the marine ascidian Eudistoma gilboverde. J. Nat. Prod. 2001, 64, 1454-1456. (Pubitemid 33116691)
63. Carney, J.R.; Scheuer, P.J.; Kelly-Borges, M. Makaluvamine G, a cytotoxic pigment from an an Indonesian Sponge Histodermella sp. Tetrahedron 1993, 49, 8483-8486.
64. Radisky, D.C.; Radisky, E.S.; Barrows, L.R.; Copp, B.R.; Kramer, R.A.; Ireland, C.M. Novel cytotoxic topoisomerase II inhibiting pyrroloiminoquinones from Fijian sponges of the genus Zyzzya. J. Am. Chem. Soc. 1993, 115, 1632-1638. (Pubitemid 23134849)
65. Matsumoto, S.S.; Haughey, H.M.; Schmehl, D.M.; Venables, D.A.; Ireland, C.M.; Holden, J.A.; Barrows, L.R. Makaluvamines vary in ability to induce dose-dependent DNA cleavage via topoisomerase II interaction. Anticancer Drugs 1999, 10, 39-45. (Pubitemid 29150179)
66. Hoang, H.; LaBarbera, D.V.; Mohammed, K.A.; Ireland, C.M.; Skibo, E.B. Synthesis and biological evaluation of imidazoquinoxalinones, imidazole analogues of pyrroloiminoquinone marine natural products. J. Med. Chem. 2007, 50, 4561-4571. (Pubitemid 47463232)
67. Labarbera, D.V.; Skibo, E.B. Synthesis of imidazo[1,5,4-de]quinoxalin-9- ones, benzimidazole analogues of pyrroloiminoquinone marine natural products. Bioorg. Med. Chem. 2005, 13, 387-395. (Pubitemid 39642921)
68. Shinkre, B.A.; Raisch, K.P.; Fan, L.; Velu, S.E. Analogs of the marine alkaloid makaluvamines: Synthesis, topoisomerase II inhibition, and anticancer activity. Bioorg. Med. Chem. Lett. 2007, 17, 2890-2893. (Pubitemid 46636250)
69. Shinkre, B.A.; Raisch, K.P.; Fan, L.; Velu, S.E. Synthesis and antiproliferative activity of benzyl and phenethyl analogs of makaluvamines. Bioorg. Med. Chem. 2008, 16, 2541-2549. (Pubitemid 351380929)
70. Wang, W.; Rayburn, E.R.; Velu, S.E.; Chen, D.; Nadkarni, D.H.; Murugesan, S.; Zhang, R. A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: In vitro and in vivo activity and mechanisms of action. Breast Cancer Res. Treat. 2010, 123, 321-331.
71. Wang, W.; Rayburn, E.R.; Velu, S.E.; Nadkarni, D.H.; Murugesan, S.; Zhang, R. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues. Clin. Cancer Res. 2009, 15, 3511-3518.
72. Wang, F.; Ezell, S.J.; Zhang, Y.; Wang, W.; Rayburn, E.R.; Nadkarni, D.H.; Murugesan, S.; Velu, S.E.; Zhang, R. FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer. Invest. New Drugs 2010, 28, 234-241.
73. Ezell, S.J.; Li, H.; Xu, H.; Zhang, X.; Gurpinar, E.; Rayburn, E.R.; Sommers, C.I.; Yang, X.; Velu, S.E.; Wang, W.; et al. Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent. Mar. Drugs 2010, 8, 2129-2141.
74. Lee, K.H.; Hall, I.H.; Mar, E.C.; Starnes, C.O.; ElGebaly, S.A.; Waddell, T.G.; Hadgraft, R.I.; Ruffner, C.G.; Weidner, I. Sesquiterpene antitumor agents: Inhibitors of cellular metabolism. Science 1977, 196, 533-536. (Pubitemid 8090468)
75. Haven, G.T.; Krzemien, J.R.; Nguyen, T.T. Study of a renal microsomal inhibitor of hepatic cholesterol synthesis in intact cell systems. Res. Commun. Chem. Pathol. Pharmacol. 1973, 6, 253-262.
76. Santoro, M.G.; Garaci, E.; Amici, C. Prostaglandins with antiproliferative activity induce the synthesis of a heat shock protein in human cells. Proc. Natl. Acad. Sci. USA 1989, 86, 8407-8411. (Pubitemid 19286067)
77. Ciucci, A.; Gianferretti, P.; Piva, R.; Guyot, T.; Snape, T.J.; Roberts, S.M.; Santoro, M.G. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: Role of the IkappaB kinase/nuclear factor-kappaB pathway. Mol. Pharmacol. 2006, 70, 1812-1821.
78. Hsiang, C.H.; Straus, D.S. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells. Oncogene 2002, 21, 2212-2226. (Pubitemid 34311375)
79. Ogi, T.; Margiastuti, P.; Teruya, T.; Taira, J.; Suenaga, K.; Ueda, K. Isolation of C11 cyclopentenones from two didemnid species, Lissoclinum sp. and Diplosoma sp. Mar. Drugs 2009, 7, 816-832.
80. You, J.; Dai, H.; Chen, Z.; Liu, G.; He, Z.; Song, F.; Yang, X.; Fu, H.; Zhang, L.; Chen, X. Trichoderone, a novel cytotoxic cyclopentenone and cholesta-7, 22-diene-3 beta, 5 alpha, 6 beta-triol, with new activities from the marine-derived fungus Trichoderma sp. J. Ind. Microbiol. Biotechnol. 2010, 37, 245-252.
81. Kazlauskas, R.; Murphy, P.T.; Quinn, R.J.; Wells, R.J. Heteronemin, a new scalarin type sesterterpene from the sponge Heteronema erecta. Tetrahedron Lett. 1976, 17, 2631-2634.
82. Walker, R.P.; Thompson, J.E.; Faulkner, D.J. Sesterpenes from Spongia idia. J. Org. Chem. 1980, 45, 4976-4979.
83. Fontana, A.; Cavaliere, P.; Ungur, N.; D'Souza, L.; Parameswaram, P.S.; Cimino, G. New scalaranes from the nudibranch Glossodoris atromarginata and its sponge prey. J. Nat. Prod. 1999, 62, 1367-1370. (Pubitemid 29504096)
84. Song, J.; Jeong, W.; Wang, N.; Lee, H.S.; Sim, C.J.; Oh, K.B.; Shin, J. Scalarane Sesterterpenes from the Sponge Smenospongia sp. J. Nat. Prod. 2008, 71, 1866-1871.
85. Wonganuchitmeta, S.N.; Yuenyongsawad, S.; Keawpradub, N.; Plubrukarn, A. Antitubercular sesterterpenes from the Thai sponge Brachiaster sp. J. Nat. Prod. 2004, 67, 1767-1770. (Pubitemid 39426143)
86. Ledroit, V.; Debitus, C.; Ausseil, F.; Raux, R.; Menou, J.L.; Hill, B.T. Heteronemin as a protein farnesyl transferase inhibitor. Pharm. Biol. 2004, 42, 454-456. (Pubitemid 40066066)
87. Schumacher, M.; Cerella, C.; Eifes, S.; Chateauvieux, S.; Morceau, F.; Jaspars, M.; Dicato, M.; Diederich, M. Heteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death. Biochem. Pharmacol. 2010, 79, 610-622.
88. Jaisamut, S.; Thengyai, S.; Yuenyongsawad, S.; Karalai, C.; Plubrukarn, A.; Suwanborirux, K. Structure-activity relationships of antitubercular scalaranes: Heteronemin revisited. Pure Appl. Chem. 2009, 81, 1019-1026.
89. Kamel, H.N.; Kim, Y.B.; Rimoldi, J.M.; Fronczek, F.R.; Ferreira, D.; Slattery, M. Scalarane sesterterpenoids: Semisynthesis and biological activity. J. Nat. Prod. 2009, 72, 1492-1496.
90. Kashman, Y.; Groweiss, A.; Shmueli, U. Latrunculin, a new 2-thiazolidinone macrolide from the marine sponge latrunculia magnifica. Tetrahedron Lett. 1980, 21, 3629-3632.
91. Spector, I.; Shochet, N.R.; Kashman, Y.; Groweiss, A. Latrunculins: Novel marine toxins that disrupt microfilament organization in cultured cells. Science 1983, 219, 493-495. (Pubitemid 13189272)
92. El Sayed, K.A.; Youssef, D.T.; Marchetti, D. Bioactive natural and semisynthetic latrunculins. J. Nat. Prod. 2006, 69, 219-223.
93. Hayot, C.; Debeir, O.; Van Ham, P.; Van Damme, M.; Kiss, R.; Decaestecker, C. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol. Appl. Pharmacol. 2006, 211, 30-40. (Pubitemid 43152095)
94. Longley, R.E.; McConnell, O.J.; Essich, E.; Harmody, D. Evaluation of marine sponge metabolites for cytotoxicity and signal transduction activity. J. Nat. Prod. 1993, 56, 915-920. (Pubitemid 23195620)
95. Newman, D.J.; Cragg, G.M. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 2004, 67, 1216-1238. (Pubitemid 39145623)
96. Newman, D.J.; Cragg, G.M.; Holbeck, S.; Sausville, E.A. Natural products and derivatives as leads to cell cycle pathway targets in cancer chemotherapy. Curr. Cancer Drug Targets 2002, 2, 279-308. (Pubitemid 35303466)
97. Morton, W.M.; Ayscough, K.R.; McLaughlin, P.J. Latrunculin alters the actin-monomer subunit interface to prevent polymerization. Nat. Cell Biol. 2000, 2, 376-378.
98. Amagata, T.; Johnson, T.A.; Cichewicz, R.H.; Tenney, K.; Mooberry, S.L.; Media, J.; Edelstein, M.; Valeriote, F.A.; Crews, P. Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges. J. Med. Chem. 2008, 51, 7234-7242.
99. Furstner, A.; Kirk, D.; Fenster, M.D.; Aissa, C.; De Souza, D.; Nevado, C.; Tuttle, T.; Thiel, W.; Muller, O. Latrunculin analogues with improved biological profiles by "diverted total synthesis": Preparation, evaluation, and computational analysis. Chemistry 2007, 13, 135-149. (Pubitemid 46033861)
100. Khanfar, M.A.; Youssef, D.T.; El Sayed, K.A. Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: Biological evaluations, preliminary structure-activity relationship and molecular modeling studies. ChemMedChem 2010, 5, 274-285.
101. El Sayed, K.A.; Khanfar, M.A.; Shallal, H.M.; Muralidharan, A.; Awate, B.; Youssef, D.T.; Liu, Y.; Zhou, Y.D.; Nagle, D.G.; Shah, G. Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells. J. Nat. Prod. 2008, 71, 396-402. (Pubitemid 351549362)
102. Abdel-Mageed, W.M.; Milne, B.F.; Wagner, M.; Schumacher, M.; Sandor, P.; Pathom-aree, W.; Goodfellow, M.; Bull, A.T.; Horikoshi, K.; Ebel, R.; et al. Dermacozines, a new phenazine family from deep-sea dermacocci isolated from a Mariana Trench sediment. Org. Biomol. Chem. 2010, 8, 2352-2362.